# Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection

> **NCT03353506** · PHASE2 · COMPLETED · sponsor: **Dina Kao** · enrollment: 11 (actual)

## Conditions studied

- Enterocolitis
- Recurrent Clostridium Difficile Infection

## Interventions

- **BIOLOGICAL:** LFMT
- **BIOLOGICAL:** LSFF

## Key facts

- **NCT ID:** NCT03353506
- **Lead sponsor:** Dina Kao
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-14
- **Primary completion:** 2019-06-05
- **Final completion:** 2019-10-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03353506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03353506, "Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03353506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*